STAGE III BLADDER CANCER AMERICAN JOINT COMMITTEE ON CANCER ( AJCC) V8

Clinical trials for STAGE III BLADDER CANCER AMERICAN JOINT COMMITTEE ON CANCER ( AJCC) V8 explained in plain language.

Never miss a new study

Get alerted when new STAGE III BLADDER CANCER AMERICAN JOINT COMMITTEE ON CANCER ( AJCC) V8 trials appear

Sign up with your email to follow new studies for STAGE III BLADDER CANCER AMERICAN JOINT COMMITTEE ON CANCER ( AJCC) V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested for aggressive bladder and prostate cancers

Disease control Ongoing

This early-stage trial is testing whether adding the immunotherapy drug pembrolizumab to standard chemotherapy works better for treating advanced small cell or neuroendocrine cancers of the bladder, urethra, or prostate. The study will enroll about 15 participants with cancer tha…

Matched conditions: STAGE III BLADDER CANCER AMERICAN JOINT COMMITTEE ON CANCER ( AJCC) V8

Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

STAGE III BLADDER CANCER AMERICAN JOINT COMMITTEE ON CANCER ( AJCC) V8

Get alerted when new STAGE III BLADDER CANCER AMERICAN JOINT COMMITTEE ON CANCER ( AJCC) V8 trials appear

New drug combo tested for aggressive bladder and prostate cancers